Skip to main content

Table 5 Univariate and multivariate Cox analysis of PFS among patients who received EGFR-TKI treatment

From: Effects of reduced platelet count on the prognosis for patients with non-small cell lung cancer treated with EGFR-TKI: a retrospective study

 

Univariate analysis

Multivariate analysis

HR

95%CI

P

HR

95%CI

P

Platelet

 (Decrease VS Increase)

0.592

0.325-1.080

0.087

   

D-dimer

 (Decrease VS Increase)

0.733

0.387-1.391

0.342

   

 Male VS Female

0.728

0.399-1.326

0.299

   

 Age (≥62.5 vs. others)

1.104

0.617-1.976

0.738

   

Substitution in exon 21

 (Yes vs. No)

0.934

0.489-1.787

0.837

   

Deletion in exon 19

 (Yes vs. No)

1.392

0.774-2.502

0.269

   

 Smoking(Yes vs. No)

1.360

0.728-2.539

0.335

   

Other treatment

 (Yes vs. No)

0.691

0.377-1.266

0.231

   

Other diseases

 (Yes vs. No)

1.254

0.695-2.263

0.452

   
  1. PFS progression-free survival, HR hazard ratio